Exclusive Interview With Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. Live on Wall Street in New York City, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 10A) live on Wall Street.

Mr. Villalba shares with us his background, information on the benefits that Latin America provides for companies in the cannabis industry, and details on various company goals.

Additionally, Mr. Villalba offers his perspective on the position of building growth and company expansion across Latin America and other regions.

Camilio Villalba is a Bilingual professional in Finance and Foreign Trade with a Master’s degree in Business Administration (MBA), specializing in Oil and Gas Industry Management. His knowledge and experience in Oil & Gas project evaluations, financial planning, budgeting and reporting have prepared him to transition into the cannabis industry and become Blueberries Medical Corp.’s Chief Operating Officer.

According to data compiled by Prohibition Partners, the Latin America cannabis legal sales were estimated at USD 125 Million in 2018 and are expected to reach USD 12.7 Billion by 2028. Medical cannabis is expected to account for more than two-thirds of the legal cannabis industry in the region, delivering an estimated USD 8.5 Billion throughout the forecast period. Countries such as PeruChileArgentina, and Colombia have all passed favorable medical cannabis laws. Meanwhile, Uruguay has legalized cannabis for both recreational and medical use. Now, Mexico’s newly elected President is considering nationwide legalization of cannabis as well.

Watch the full HD Video Interview now to learn more about the buzz surrounding Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 10A)

Click Here for full HD video interview:

About Blueberries Medical Corp. (

Blueberries is a Colombia-based licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia. Led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

About Financial Buzz Media  

Located on Wall Street in the heart of New York City’s financial district,, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news wire services, dissemination, branding, marketing and advertising for companies directly or third parties for corporate news and original content creation through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

For “The Latest Buzz in Financial News” every day, please visit:

Please Sign up Now at to receive alerts on trending financial news from all these companies. “The Latest Buzz in Financial News”

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook – Like Us to receive live feeds:

[popuppress id=”217258″]

  1. Doug Grant 3 years ago

    The medical cannabis market has more potential than the recreational at the moment imo. Many still have not opened up to utilizing cannabis to treat illness but as more information on cannabis surfaces on mainstream outlets. It will become apparent that cannabis can replace many addictive opioids on the market today, great interview

    • Charlotte Weiss 3 years ago

      I’m interested in seeing the change in Medical Cannabis and the Legal Implications for Primary Care Providers in the short term future as it becomes more prevalent that it is more beneficial to use than addictive opioids

  2. Nate Mckinney 3 years ago

    #Australia’s medical cannabis market could surpass 15,000 patient application approvals by the end of this year, with industry revenues totaling roughly 36 million Australian dollars ($25 million). How does this compare with Latin America’s Medical Cannabis market?

Leave a Comment